Announce Date | 08/07/2025 |
EPS Normalized Actual | $0.97 (Beat by $0.11) |
EPS GAAP Actual | $0.97 (Beat by $0.11) |
Revenue Actual | $1.25436B |
Revenue Surprise | Beat by $1254.36M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.96256 |
EPS GAAP Estimate | $0.96256 |
Revenue Estimate | $1.37821487B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2028 | 3.45399 | 9.17 | 3.39033 | 3.51504 | 1 |
Jun 2027 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.35 | -0.52783 | 1.25436B | -15.37% | -82.1M |
FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 1.3345B | -15.01% | 1334.5M |
FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 1.26901B | -12.33% | 1269.01M |
FQ2 2024 (Jun 2024) | 915.37 | 915.37 | 1362.15B | 99.89% | 1362150M |
FQ1 2024 (Mar 2024) | 0.36 | 0.36 | 1.44713B | 13.99% | 1447.13M |
FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 1.53487B | 41.53% | 1534.87M |
FQ3 2023 (Sep 2023) | 0.3 | 0.3 | 1.42543B | 40.23% | 1425.43M |
FQ2 2023 (Jun 2023) | -0.18 | -0.18 | 1.49083B | 39.47% | 1490.83M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.96256
Consensus Revenue Estimates
1.37821487B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.03269 | -- | 1.02873 | 1.03663 | 4 |
FQ4 2027 (Dec 2027) | 1.31163 | -- | 1.3066 | 1.31663 | 6 |
FQ3 2027 (Sep 2027) | 1.1087 | -- | 1.10445 | 1.11293 | 3 |
FQ1 2027 (Mar 2027) | 1.28661 | -- | 1.27011 | 1.30635 | 3 |
FQ4 2026 (Dec 2026) | 1.42733 | -- | 1.40903 | 1.44923 | 3 |
FQ3 2026 (Jul 2026) | 1.14562 | -- | 1.13994 | 1.14861 | 0 |
FQ1 2026 (Mar 2026) | 1.21408 | 71.17 | 1.20196 | 1.23602 | 3 |
FQ4 2025 (Oct 2025) | 0.97245 | 10.54 | 0.96763 | 0.97499 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 1.31B | -- | 1.3B | 1.31B | 2 |
FQ4 2027 (Dec 2027) | 1.39B | -- | 1.39B | 1.4B | 3 |
FQ3 2027 (Sep 2027) | 1.3B | -- | 1.29B | 1.3B | 3 |
FQ1 2027 (Mar 2027) | 2.09B | -- | 2.07B | 2.12B | 4 |
FQ4 2026 (Dec 2026) | 2.01B | -- | 1.99B | 2.04B | 4 |
FQ3 2026 (Jul 2026) | 1.42B | -- | 1.41B | 1.42B | 1 |
FQ1 2026 (Mar 2026) | 1.43B | 12.38 | 1.42B | 1.45B | 2 |
FQ4 2025 (Oct 2025) | 1.33B | -0.2 | 1.33B | 1.33B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.87783 | 0.35 | -0.52783 | -150.81% |
FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 100% | |
FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 100% | |
FQ2 2024 (Jun 2024) | 915.37 | 915.37 | 100% | |
FQ1 2024 (Mar 2024) | 0.36 | 0.36 | 100% | |
FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 100% | |
FQ3 2023 (Sep 2023) | 0.3 | 0.3 | 100% | |
FQ2 2023 (Jun 2023) | -0.18 | -0.18 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.34B | $1.25B | $-82.1M | -6.55% |
FQ4 2024 (Dec 2024) | $0B | $1.33B | $1334.5M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.27B | $1269.01M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1362.15B | $1362150M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.45B | $1447.13M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.53B | $1534.87M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.43B | $1425.43M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.49B | $1490.83M | 100% |